
Opinion|Videos|September 25, 2024
Type 2 Inflammation Biomarkers
Panelists discuss how biomarkers of type 2 inflammation, such as blood eosinophils, serum IgE, and fractional exhaled nitric oxide, can aid in diagnosing and monitoring type 2 inflammatory diseases as well as in predicting treatment response.
Advertisement
Episodes in this series

- What tests or biomarkers are used to determine if a patient’s disease may be caused by type 2 inflammation? How does this information aid your medication selection process?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Medicaid Work Requirements Set to Leave Millions Without Insurance
2
AMCP Nexus 2025: Advancing Health Policy and Patient Outcomes Together
3
Most Favored Nation Drug Pricing Moves Forward, but Experts Warn Details Are Still Missing
4
Changing Tumor Classifications May Explain Rise in Early-Onset CRC
5


















































